(Liu Meiyan, a reporter from the Peoples Daily Health Client) On November 13, Beijing time, a large -scale, multi -center, random control, and double -blind test method was used to evaluate the "stroke and brain prescription" of the Chinese medicine preparation. (The main components are red ginseng, Sanqi, Chuanxiong, rhubarb) The clinical study of the efficacy of the internationally renowned medical journal "The Lancet".
Researchers have found that the "stroke and brain" has not improved significantly on the clinical prognosis of patients with acute cerebral hemorrhage as a whole, but Bleeding patients show potential effects (to be further verified).The study was jointly completed by Guo Jianwen team of Guangdong Provincial Hospital of Traditional Chinese Medicine, Song Lili and Craig Anderson team of Fudan University, and Craig Anderson.
On November 13, Guo Jianwen told the Peoples Daily Health Client reporter that the research was the first time in 1823, the "Liuye Knife" magazine has published the Chinese herbal multi -center clinical clinical clinical for the first time in 1823. Studies have a milestone.
Guo Jianwen said that spontaneous cerebral hemorrhage is the most serious and the least treatment method, which leads to two-thirds of patients died or The disabled, and the current effective treatment methods are very limited, urgently need to develop effective drugs to improve the ending of patients.
"Stroke Wake Brain" is a Chinese medicine compound preparation made from Professor Chen Shaohong, a master of Chinese medicine, and is clinically used for acute cerebral hemorrhage for more than 20 years.In order to verify the clinical effectiveness and safety of the "stroke", the research team carried out a three -year forward -looking, multi -centered, random, and placebo -controlled double -blind test.
"We have used a test method of completely international standardization to evaluate the efficacy of Chinese medicine." Guo Jianwen introduced that this study covers 26 hospitals in 12 provinces in China, which is included in total. 1648 patients with acute cerebral hemorrhage.The test did not show that the "stroke wake -up" can improve the functional prognosis, survival rate, and quality of life of patients with medium to severe cerebral hemorrhage, but confirmed the safety of the drug, and the two groups of adverse reactions were not significantly different.
In the preset sub -group analysis, the two sub -groups of the brain bleeding greater than 15 ml and brain bleeding showed potential benefits of Chinese medicine, prompting to further develop Chinese medicine Treatment of clinical trials of patients with large hematoma and confirming the efficacy.
On October 23, the research was invited to give a lecture at the 16th World Stroke Conference (WSC). The Valeria Caso believes that the research design is rigorous and well implemented. Through high -quality research, Chinese medicine shows that it has a very promising treatment effect on larger hematoma patients, giving patients with severe cerebral hemorrhage patients with more survival and recovery of disability. Hope.Professor Jeyaraj Pandian, chairman of the World Stroke Organization, praised the study "using scientific data to promote traditional medicine to the world."
